Alaunos Therapeutics Inc (STU:WEK)
€ 1.66 0 (-4.82%) Market Cap: 338.23 Mil Enterprise Value: 276.94 Mil PE Ratio: 0 PB Ratio: 1.04 GF Score: 54/100

Q4 2019 ZIOPHARM Oncology Inc Earnings Call Transcript

Mar 02, 2020 / 09:30PM GMT
Release Date Price: €2.72 (+2.26%)
Operator

Ladies and gentlemen, thank you for standing by. And welcome to the Ziopharm Oncology Fourth Quarter and Year-End 2019 Conference Call. (Operator Instructions) Please be advised today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Mr. Chris Taylor, Vice President of Investor Relations. Thank you. Please go ahead.

Christopher Taylor
ZIOPHARM Oncology, Inc. - VP of IR & Corporate Communications

Thank you, operator, afternoon, and welcome to the Ziopharm Oncology conference call and webcast to review results for the fourth quarter of 2019. This afternoon, we filed our 10-K and issued our 2019 year-end results release, both of which are available in the Investors section of our website, ziopharm.com. For informational purposes, we have also included in our webcast, a set of PowerPoint slides to accompany today's commentary these slides can also be found on our website in the Investors section. During this call, the company will make a number of forward-looking statements,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot